Ruthie Amir

Dr. Ruthie Amir joined Epitomee Medical as the chief medical officer in 2018. Prior to joining Epitomee Medical Ruthie served as the director of clinical research and the head of the regulatory department of Syneron Candela from 2008 to 2017. Ruthie graduated from Ben Gurion University Medical School. From 1996-2000, she completed her post-doctoral fellowship in the Department of Human Genetics, at Baylor College of Medicine, Houston, the USA where she worked on the genetic basis of Rett Syndrome. Between 2000-2003 she completed a post-doctoral fellowship in the Department of Cell Biology, Faculty of Medicine, Technion.